Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes inadequately controlled by glyburide monotherapy Article

cited authors

  • Pratley, R. E.; Kipnes, M. S.; Fleck, P. R.; Wilson, C.; Mekki, Q.; Alogliptin Study Grp

authors

Publication Date

  • February 1, 2009

webpage

published in

category

keywords

  • alogliptin
  • dipeptidyl peptidase-4 inhibitors
  • glucagon-like peptide-1
  • sulphonylurea
  • type 2 diabetes mellitus

start page

  • 167

end page

  • 176

volume

  • 11

issue

  • 2